Finance
Cardiol Therapeutics Inc (CRDL) Is A Stock Worth Accumulating At Current Levels
Cardiol Therapeutics Inc (NASDAQ:CRDL) concluded the trading at $1.58 on Wednesday, November 27, with a rise of 3.27% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.53 and 5Y monthly beta
